|
|
||||||||
Ann Thorac Surg 2004;78:1783-1789
© 2004 The Society of Thoracic Surgeons
a Department of Surgery, The University of Chicago, Chicago, Illinois, USA
Accepted for publication April 27, 2004.
* Address reprint requests to Dr Ferguson, Department of Surgery, 5841 S Maryland Ave MC5035, Chicago, IL 60637, USA
mferguso{at}surgery.bsd.uchicago.edu
BACKGROUND: A complete pathological response after induction therapy for esophageal cancer offers survival benefits, but induction therapy may increase the risk of postoperative complications and mortality.
METHODS: We performed a retrospective review of consecutive patients who underwent esophagectomy for esophageal cancer to identify preoperative predictors of complications and assess the possible influence of induction therapy on surgical outcomes.
RESULTS: Between 1988 and 2003, 170 esophagectomies were performed on our service; 95 (55.9%) underwent surgery alone and 75 (44.1%) received preoperative chemotherapy, 35 of whom also had preoperative radiation therapy. Based on multivariable regression analyses, independent covariates for complication categories included performance status (pulmonary, cardiovascular, total complications, and death), age (cardiovascular and other complications), and FEV1% (pulmonary complications). Whether patients received induction therapy was unrelated to the incidence of postoperative complications.
CONCLUSIONS: We found no evidence that induction therapy adversely influences the incidence of postoperative morbidity or mortality after esophagectomy for cancer.
This article has been cited by other articles:
![]() |
T. D. Luu, P. Gaur, S. D. Force, C. A. Staley, K. A. Mansour, J. I. Miller Jr, and D. L. Miller Neoadjuvant Chemoradiation Versus Chemotherapy for Patients Undergoing Esophagectomy for Esophageal Cancer Ann. Thorac. Surg., April 1, 2008; 85(4): 1217 - 1224. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ruol, G. Portale, C. Castoro, S. Merigliano, M. Cagol, F. Cavallin, V. C. Sileni, L. Corti, S. Rampado, M. Costantini, et al. Effects of Neoadjuvant Therapy on Perioperative Morbidity in Elderly Patients Undergoing Esophagectomy for Esophageal Cancer Ann. Surg. Oncol., November 1, 2007; 14(11): 3243 - 3250. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shiraishi, K. Kawahara, T. Shirakusa, S. Yamamoto, and T. Maekawa Risk Analysis in Resection of Thoracic Esophageal Cancer in the Era of Endoscopic Surgery. Ann. Thorac. Surg., March 1, 2006; 81(3): 1083 - 1089. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |